Skip to content

Juno therapeutics stock price

Juno therapeutics stock price

Juno Therapeutics | Crunchbase Juno Therapeutics is registered under the ticker NASDAQ:JUNO . Their stock opened with $24.00 in its Dec 19, 2014 IPO. Stock Symbol NASDAQ:JUNO Valuation at IPO $1.7B Money Raised at IPO $264.6M IPO Share Price $24.00 IPO Date Dec 19, 2014 Delisted Date Mar 5, 2018 10-Q: JUNO THERAPEUTICS, INC. - MarketWatch Aug 03, 2017 · Unless the context requires otherwise, in this Quarterly Report on Form 10-Q, the terms "Juno," "Company," "we," "us" and "our" refer to Juno Therapeutics, Inc., a Delaware corporation, and its

Juno Therapeutics, Inc. (delisted) Share Price History ...

Juno Therapeutics | Crunchbase Juno Therapeutics is registered under the ticker NASDAQ:JUNO . Their stock opened with $24.00 in its Dec 19, 2014 IPO. Stock Symbol NASDAQ:JUNO Valuation at IPO $1.7B Money Raised at IPO $264.6M IPO Share Price $24.00 IPO Date Dec 19, 2014 Delisted Date Mar 5, 2018 10-Q: JUNO THERAPEUTICS, INC. - MarketWatch Aug 03, 2017 · Unless the context requires otherwise, in this Quarterly Report on Form 10-Q, the terms "Juno," "Company," "we," "us" and "our" refer to Juno Therapeutics, Inc., a Delaware corporation, and its

JUNO THERAPEUTICS, INC. Stock Quote. JUNO - Stock Price ...

Mar 06, 2018 · Real-time trade and investing ideas on Juno Therapeutics JUNO from the largest community of traders and investors. Market Data by Xignite and BATS BZX Real-Time Price. LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, 1877 (JUNO) Stock Historical Prices & Data - Yahoo Finance Discover historical prices for JUNO stock on Yahoo Finance. View daily, weekly or monthly format back to when 1877 stock was issued. Juno Therapeutics PRE 14A Apr 5 2016 | Seeking Alpha

Presenting JUNO historical stock prices and CAGR performance. End price/ share: $86.96. Dividends collected/share: $0.00. Total return: 60.41%. Average 

Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies. JUNO Historical Stock Prices JUNO (JUNO) has the following price history information. Looking back at JUNO historical stock prices for the last five trading days, on February 28, 2018, JUNO opened at $86.67, traded as high as $86.83 and as low as $86.65, and closed at $86.77. Trading volume was a total of 1.05M shares. Juno Therapeutics (JUNO) Stock Analysis & News | Seeking Alpha Get breaking news and analysis on Juno Therapeutics (JUNO) stock, price quote and chart, trading and investing tools.

Jan 17, 2018 · Celgene focuses more on blood related disorders and cancers. The regular training session saw Juno Therapeutics close down -$3.15 which was down 6.46% on the day. However in the aftermarket session, shares rocketed up and closed at $65.10 or up $19.50 which is 42.76% after the news was announced and the reaction in the stock price developed.

About Juno | Our Story | Juno Therapeutics More than 25 years ago, researchers at Fred Hutchinson Research Center, Memorial Sloan Kettering Cancer Center and Seattle Children’s Research Institute and elsewhere were working in the lab on the development of T cells against foreign antigens. JUNO THERAPEUTICS, INC. More Historical Data - JUNO | ADVFN Mar 18, 2020 · Historical prices for JUNO THERAPEUTICS, INC. with share price and JUNO stock charts. Free real-time prices, and the most active stock market forums.

Apex Business WordPress Theme | Designed by Crafthemes